David Domzalski - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
David Domzalski has filed 3 SEC Form 4 filings across 1 company in the last 90 days.
Profile
David Domzalski is a corporate insider at VYNE Therapeutics Inc. (VYNE). Domzalski has reported 8 insider filings with the SEC since 2024. The most recent filing was in July 2026.
| Role | PRESIDENT AND CEO |
|---|---|
| Notability | 20/100 |
Board memberships
- VYNE Therapeutics Inc.
Awards & honors
- Leadership in developing therapies for immuno-inflammatory conditions
- Oversight of product candidates like FMX114
- Management of a small biopharmaceutical company
Trading Pattern
InsiderAlpha's records for David Domzalski go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role David Domzalski has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- PRESIDENT AND CEO at Yarrow Bioscience, Inc. (YARW) - 8 filings, 2024 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-24 | YARW | Yarrow Bioscience, Inc. | F - Tax withholding / forfeiture | 79.4K | $0.90 | $71K |
| 2026-07-03 | YARW | Yarrow Bioscience, Inc. | F - Tax withholding / forfeiture | 12.2K | $0.65 | $8K |
| 2026-06-02 | YARW | Yarrow Bioscience, Inc. | A - Grant or award | 30.8K | $0.31 | $10K |
| 2026-04-02 | YARW | Yarrow Bioscience, Inc. | F - Tax withholding / forfeiture | 14.2K | $0.60 | $9K |
| 2025-09-30 | YARW | Yarrow Bioscience, Inc. | F - Tax withholding / forfeiture | 12.7K | $0.34 | $4K |
| 2025-06-30 | YARW | Yarrow Bioscience, Inc. | F - Tax withholding / forfeiture | 12.7K | $1.65 | $21K |
| 2024-12-03 | YARW | Yarrow Bioscience, Inc. | A - Grant or award | 3.9K | $2.10 | $8K |
| 2024-10-02 | YARW | Yarrow Bioscience, Inc. | F - Tax withholding / forfeiture | 685 | $1.88 | $1K |
Companies - Last 90 Days
- Yarrow Bioscience, Inc. (YARW) - 3 filings, last 2026-07-24
Most Active Insiders Right Now
David Domzalski has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Charles A. Davis
- Deep Track Biotechnology Master Fund, Ltd.
- Robert E. Dixon
- Romeo R. Dizon
- Kevin Michael Donahue
- DONEGAL MUTUAL INSURANCE CO
- DORCHESTER MINERALS OPERATING LP
- Robert W. Duggan
Frequently Asked Questions
Who is David Domzalski?
David Domzalski is a corporate insider at VYNE Therapeutics Inc. (VYNE). Domzalski has reported 8 insider filings with the SEC since 2024. The most recent filing was in July 2026.…
How many SEC Form 4 filings has David Domzalski submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of David Domzalski's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live David Domzalski profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.